Global Investor Forum Contact

André van de Sande

CEO, Xendo

Session(s)

09:00 - 09:45
PharmInvestHolland: Make the Netherlands more attractive for R&D in pharma

14:15 - 15:25 hours
From research to innovation

Track Leader

Senior Executive with over 25 years of Life Sciences experience in both mature and emerging markets in Western and Central Europe, Asia Pacific and Middle East Africa. Has successfully managed country and regional teams of up to 1100 employees and a turnover of €350 million. Extensive change management experience. Broad Non Executive and Advisory board experience with a.o. Lloyds Pharmacies and as chairman of BioFarmind(HollandBio). Leads now since more than six years Dutch Consultancy firm Xendo. Holds a MBA degree from Tilburg university, The Netherlands and a MSc in Management from Purdue University, USA. Followed also the supervisory board member program of Nyenrode University. Fluent in Dutch, English and German. Reasonable knowledge of French and Hungarian
Niels Chavannes
LUMC
Maarten van Dongen
LabForRent
Ingmar de Gooijer
myTomorrows
Mark van Houdenhoven
Sint Maartenskliniek

Henk van Houten
Philips

Arthur Lahr
Kiadis Pharma

Jos Malda
UMC Utrecht
Eveliene Manten-Horst
AYA Jongvolwassen & Kanker

Madelon Maurice
UMC Utrecht

Tom Miller
GreyBird Ventures
Edwin Moses
Ablynx
Kees Recourt
Mibiton Foundation

Maurits van Selms
ACTA

Marianne van der Steen
MERLN
Markwin Velders
Kite Pharma
Werner Verbiest
Janssen Diagnostics
Eline Vrijland-van Beest
NightBalance
Sponsors & Partners
Main partner
Host sponsor
Host sponsor
Host sponsor
Platinum sponsor
Gold sponsor
Partner
Partner
Award sponsor
Your logo?
© 2018 Innovation for Health